[1] GAREAU M G, SILVA M A, PERDUE M H.Pathophysiological mechanisms of stress-induced intestinal damage[J].Current Molecular Medicine, 2008, 8(4):274-281.
[2] GOEHLER L E, PARK S M, OPITZ N, et al.Campylobacter jejuni infection increases anxiety-like behavior in the holeboard:possible anatomical substrates for viscerosensory modulation of exploratory behavior[J].Brain, Behavior, and Immunity, 2008, 22(3):354-366.
[3] LYTE M, LI W, OPITZ N, et al.Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium[J].Physiology & Behavior, 2006, 89(3):350-357.
[4] MACPHERSON A J, UHR T.Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria[J].Science, 2004, 303(5664):1662-1665.
[5] TEITELBAUM A A, GAREAU M G, JURY J, et al.Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress[J].American Journal of Physiology:Gastrointestinal and Liver Physiology, 2008, 295(3):G452-G459.
[6] DIAMANT M, BLAAK E E, DE VOS W M.Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes[J].Obesity Reviews, 2011, 12(4):272-281.
[7] LAY C, SUTREN M, ROCHET V, et al.Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota[J].Environmental Microbiology, 2010, 7(7):933-946.
[8] LESER T D, AMENUVOR J Z, JENSEN T K, et al.Culture-independent analysis of gut bacteria:the pig gastrointestinal tract microbiota revisited[J].Applied and Environmental Microbiology, 2002, 68(2):673-690.
[9] CHI Z, RONG Y J, LI Y, et al.Biosurfactins production by Bacillus amyloliquefaciens R3 and their antibacterial activity against multi-drug resistant pathogenic E. coli[J].Bioprocess and Biosystems Engineering, 2015, 38(5):853-861.
[10] RAVU R R, JACOB M R, CHEN X L, et al.Bacillusin A, an antibacterial macrodiolide from Bacillus amyloliquefaciens AP183[J].Journal of Natural Products, 2015, 78(4):924-928.
[11] CHEN X H, KOUMOUTSI A, SCHOLZ R, et al.Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42[J].Nature Biotechnology, 2007, 25(9):1007-1014.
[12] MANZOOR S, NIAZI A, BEJAI S, et al.Genome sequence of a plant-associated bacterium, Bacillus amyloliquefaciens strain UCMB5036[J].Genome Announcements, 2013, 1(2):e00111-13.
[13] LARSEN N, THORSEN L, KPIKPI E N, et al.Characterization of Bacillus spp. strains for use as probiotic additives in pig feed[J].Applied Microbiology and Biotechnology, 2014, 98(3):1105-1118.
[14] 郭政宏, 周彪, 严亨秀.藏猪源解淀粉芽孢杆菌的益生性、安全性和应用性研究[J].江苏农业科学, 2017, 45(14):137-140.
[15] 卞丽娟.鸡源解淀粉芽孢杆菌的分离鉴定及其对肉鸡的饲用效果[D].硕士学位论文.广州:华南农业大学, 2016.
[16] YUAN J, ZHANG F, WU Y, et al.Recovery of several cell pellet-associated antibiotics produced by Bacillus amyloliquefaciens NJN-6[J].Letters in Applied Microbiology, 2014, 59(2):169-176.
[17] DEBOIS D, JOURDAN E, SMARGIASSO N, et al.Spatiotemporal monitoring of the antibiome secreted by Bacillus biofilms on plant roots using MALDI mass spectrometry imaging[J].Analytical Chemistry, 2014, 86(9):4431-4438.
[18] 邓建良, 刘红彦, 刘玉霞, 等.解淀粉芽孢杆菌YN-1抑制植物病原真菌活性物质鉴定[J].植物病理学报, 2010, 40(2):202-209.
[19] 牛力轩.深海来源解淀粉芽孢杆菌SH-B74抗植物病原真菌活性产物的研究[D].硕士学位论文.北京:中国科学院研究生院, 2011.
[20] 姜威, 李晶, 孟利强, 等.解淀粉芽孢杆菌TF28抗菌蛋白AP1的表达、纯化与抑菌活性[J].基因组学与应用生物学, 2016, 35(11):3083-3087.
[21] WONG J H, HAO J, CAO Z, et al.An antifungal protein from Bacillus amyloliquefaciens[J].Journal of Applied Microbiology, 2010, 105(6):1888-1898.
[22] HERZNER A M, DISCHINGER J, SZEKAT C, et al.Expression of the lantibiotic mersacidin in Bacillus amyloliquefaciens FZB42[J].PLoS One, 2011, 6(7):e22389.
[23] KIM Ⅱ P, CHUNG K C.Production of an antifungal protein for control of Colletotrichum lagenarium by Bacillus amyloliquefaciens MET0908[J].FEMS Microbiology Letters, 2004, 234(1):177-183.
[24] ALFONZO A, LO PICCOLO S, CONIGLIARO G, et al.Antifungal peptides produced by Bacillus amyloliquefaciens AG1 active against grapevine fungal pathogens[J].Annals of Microbiology, 2012, 62(4):1593-1599.
[25] LEE A R, KIM G M, PARK J Y, et al.Characterization of a 27 kDa fibrinolytic enzyme from Bacillus amyloliquefaciens CH86-1 isolated from cheonggukjang[J].Journal of the Korean Society for Applied Biological Chemistry, 2010, 53(1):56-61.
[26] LEE A R, KIM G M, KWON G H, et al.Cloning of AprE86-1 gene encoding 27 kDa mature fibrinolytic enzyme from Bacillus amyloliquefaciens CH86-1[J].Journal of Microbiology and Biotechnology, 2010, 20(2):370-374.
[27] PENG Y, YANG X J, ZHANG Y Z.Microbial fibrinolytic enzymes:an overview of source, production, properties, and thrombolytic activity in vivo[J].Applied Microbiology and Biotechnology, 2005, 69(2):126-132.
[28] GOODSON J R, KLUPT S, ZHANG C X, et al.LoaP is a broadly conserved antiterminator protein that regulates antibiotic gene clusters in Bacillus amyloliquefaciens[J].Nature Microbiology, 2017, 2:17003.
[29] CHEN X H, SCHOLZ R, BORRISS M, et al.Difficidin and bacilysin produced by plant-associated Bacillus amyloliquefaciens are efficient in controlling fire blight disease[J].Journal of Biotechnology, 2009, 140(1/2):38-44.
[30] CAWOY H, DEBOIS D, FRANZIL L, et al.Lipopeptides as main ingredients for inhibition of fungal phytopathogens by Bacillus subtilis/amyloliquefaciens[J].Microbial Biotechnology, 2015, 8(2):281-295.
[31] YOSHIDA S, HIRADATE S, TSUKAMOTO T, et al.Antimicrobial activity of culture filtrate of Bacillus amyloliquefaciens RC-2 isolated from mulberry leaves[J].Phytopathology, 2001, 91(2):181-187.
[32] 桑建伟, 杨扬, 陈奕鹏, 等.内生解淀粉芽孢杆菌BEB17脂肽类和聚酮类化合物的抑菌活性分析[J].植物病理学报, 2018, 48(3):402-412.
[33] ARREBOLA E, JACOBS R, KORSTEN L.Iturin A is the principal inhibitor in the biocontrol activity of Bacillus amyloliquefaciens PPCB004 against postharvest fungal pathogens[J].Journal of Applied Microbiology, 2010, 108(2):386-395.
[34] CHEN L L, WANG N, WANG X M, et al.Characterization of two anti-fungal lipopeptides produced by Bacillus amyloliquefaciens SH-B10[J].Bioresource Technology, 2010, 101(22):8822-8827.
[35] 向亚萍, 周华飞, 刘永锋, 等.解淀粉芽孢杆菌B1619脂肽类抗生素的分离鉴定及其对番茄枯萎病菌的抑制作用[J].中国农业科学, 2016, 49(15):2935-2944.
[36] STÖVER A G, DRIKS A.Regulation of synthesis of the Bacillus subtilis transition-phase, spore-associated antibacterial protein TasA[J].Journal of Bacteriology, 1999, 181(17):5476-5481
[37] 王选, 王世英, 王增利, 等.牛源抗腹泻芽孢益生菌的分离与N-4菌株的鉴定[J].河南农业科学, 2009(12):132-135.
[38] 曹广添.解淀粉芽孢杆菌的抑菌机理及对肉鸡生长代谢和盲肠微生物菌群的影响[D].博士学位论文.杭州:浙江大学, 2015.
[39] 杨继业, 郭晓军, 郭威, 等.产有机酸芽孢杆菌的筛选、鉴定及产芽孢条件优化[J].饲料工业, 2015, 36(4):44-51.
[40] 程敏, 徐秋芳.解淀粉芽孢杆菌植物亚种CGMCC 11640对山核桃干腐病菌的抑制机制[J].浙江农林大学学报, 2017, 34(2):326-331.
[41] AL-AJLANI M M, SHEIKH M A, AHMAD Z, et al.Production of surfactin from Bacillus subtilis MZ-7 grown on pharmamedia commercial medium[J].Microbial Cell Factories, 2007, 6:17.
[42] 付瑞敏, 常慧萍, 陈五岭.Bacillus amyloliquefaciens BA-16-8所产fengycin对扩展青霉细胞的抑制机制研究[J].食品科技, 2017, 42(5):7-13.
[43] JI J, HU S L, ZHENG M Z, et al.Bacillus amyloliquefaciens SC06 inhibits ETEC-induced pro-inflammatory responses by suppression of MAPK signaling pathways in IPEC-1 cells and diarrhea in weaned piglets[J].Livestock Science, 2013, 158(1/2/3):206-214.
[44] 计坚.解淀粉芽孢杆菌SC06介导猪肠道免疫机理的研究[D].博士学位论文.杭州:浙江大学, 2013.
[45] 沈勇涛.芽孢杆菌对母猪仔猪微生态的影响及其生长条件优化[D].硕士学位论文.武汉:华中农业大学, 2011:34-42.
[46] 宁豫昌, 张晓静, 乔宏兴.猪肠道中产蛋白酶解淀粉芽孢杆菌的筛选、鉴定及其酶学性质的初步研究[J].中国畜牧兽医, 2017, 44(8):2398-2407.
京公网安备 11010802041926号